Model for studying virus attachment: Identification and quantitation of Epstein-Barr virus-binding cells by using biotinylated virus in flow cytometry

G. Inghirami, M. Nakamura, J. E. Balow, A. L. Notkins, Paolo Casali

Research output: Contribution to journalArticle

59 Citations (Scopus)

Abstract

Epstein-Barr virus (EBV) was purified and biotinylated without significant loss of its cell-transforming activity. The use of biotinylated virus in conjunction with antibodies specific for selected cell surface molecules and flow cytometric analysis allowed for the positive identification of the virus-binding lymphocytes among a heterogeneous mononuclear cell population. Biotinylated EBV efficiently bound to all B lymphocytes, including those bearing surface μ, δ, γ and α immunoglobulin heavy chains or the surface CD5 (Leu-1) marker, but not to T lymphocytes, natural killer cells. or monocytes. By using biotinylated EBV and specific monoclonal antibodies in competitive inhibition experiments, it was also found that the virus attaches to an epitope on the CR2 molecule (the receptor for C3d and EBV), which is close to or identical with the one recognized by OKB7 monoclonal antibody, and that cell surface structures other than CR2 cannot mediate attachment of EBV. Moreover, studies on the binding of the virus to induced B lymphocytes at different stages of the cell cycle revealed that the virus failed to transform proliferating B lymphocytes (cells in S through G2 phase), and this was associated with the disappearance of the surface CR2 molecule and the inability of the virus to attach to these cells. The approach described here should be useful in studying the attachment of other viruses, identifying the specific cell types involved, and analyzing the effect of the cell cycle on virus binding.

Original languageEnglish (US)
Pages (from-to)2453-2463
Number of pages11
JournalJournal of Virology
Volume62
Issue number7
StatePublished - Jan 1 1988
Externally publishedYes

Fingerprint

Virus Attachment
Human herpesvirus 4
Human Herpesvirus 4
flow cytometry
Flow Cytometry
Viruses
viruses
cells
B-Lymphocytes
B-lymphocytes
Cell Cycle
Complement 3d Receptors
cell cycle
Monoclonal Antibodies
monoclonal antibodies
Immunoglobulin Heavy Chains
B-Cell Antigen Receptors
immunoglobulin heavy chains
G2 Phase
natural killer cells

ASJC Scopus subject areas

  • Microbiology
  • Immunology
  • Insect Science
  • Virology

Cite this

Model for studying virus attachment : Identification and quantitation of Epstein-Barr virus-binding cells by using biotinylated virus in flow cytometry. / Inghirami, G.; Nakamura, M.; Balow, J. E.; Notkins, A. L.; Casali, Paolo.

In: Journal of Virology, Vol. 62, No. 7, 01.01.1988, p. 2453-2463.

Research output: Contribution to journalArticle

@article{e1523322e07c469cabe74673ad0c0181,
title = "Model for studying virus attachment: Identification and quantitation of Epstein-Barr virus-binding cells by using biotinylated virus in flow cytometry",
abstract = "Epstein-Barr virus (EBV) was purified and biotinylated without significant loss of its cell-transforming activity. The use of biotinylated virus in conjunction with antibodies specific for selected cell surface molecules and flow cytometric analysis allowed for the positive identification of the virus-binding lymphocytes among a heterogeneous mononuclear cell population. Biotinylated EBV efficiently bound to all B lymphocytes, including those bearing surface μ, δ, γ and α immunoglobulin heavy chains or the surface CD5 (Leu-1) marker, but not to T lymphocytes, natural killer cells. or monocytes. By using biotinylated EBV and specific monoclonal antibodies in competitive inhibition experiments, it was also found that the virus attaches to an epitope on the CR2 molecule (the receptor for C3d and EBV), which is close to or identical with the one recognized by OKB7 monoclonal antibody, and that cell surface structures other than CR2 cannot mediate attachment of EBV. Moreover, studies on the binding of the virus to induced B lymphocytes at different stages of the cell cycle revealed that the virus failed to transform proliferating B lymphocytes (cells in S through G2 phase), and this was associated with the disappearance of the surface CR2 molecule and the inability of the virus to attach to these cells. The approach described here should be useful in studying the attachment of other viruses, identifying the specific cell types involved, and analyzing the effect of the cell cycle on virus binding.",
author = "G. Inghirami and M. Nakamura and Balow, {J. E.} and Notkins, {A. L.} and Paolo Casali",
year = "1988",
month = "1",
day = "1",
language = "English (US)",
volume = "62",
pages = "2453--2463",
journal = "Journal of Virology",
issn = "0022-538X",
publisher = "American Society for Microbiology",
number = "7",

}

TY - JOUR

T1 - Model for studying virus attachment

T2 - Identification and quantitation of Epstein-Barr virus-binding cells by using biotinylated virus in flow cytometry

AU - Inghirami, G.

AU - Nakamura, M.

AU - Balow, J. E.

AU - Notkins, A. L.

AU - Casali, Paolo

PY - 1988/1/1

Y1 - 1988/1/1

N2 - Epstein-Barr virus (EBV) was purified and biotinylated without significant loss of its cell-transforming activity. The use of biotinylated virus in conjunction with antibodies specific for selected cell surface molecules and flow cytometric analysis allowed for the positive identification of the virus-binding lymphocytes among a heterogeneous mononuclear cell population. Biotinylated EBV efficiently bound to all B lymphocytes, including those bearing surface μ, δ, γ and α immunoglobulin heavy chains or the surface CD5 (Leu-1) marker, but not to T lymphocytes, natural killer cells. or monocytes. By using biotinylated EBV and specific monoclonal antibodies in competitive inhibition experiments, it was also found that the virus attaches to an epitope on the CR2 molecule (the receptor for C3d and EBV), which is close to or identical with the one recognized by OKB7 monoclonal antibody, and that cell surface structures other than CR2 cannot mediate attachment of EBV. Moreover, studies on the binding of the virus to induced B lymphocytes at different stages of the cell cycle revealed that the virus failed to transform proliferating B lymphocytes (cells in S through G2 phase), and this was associated with the disappearance of the surface CR2 molecule and the inability of the virus to attach to these cells. The approach described here should be useful in studying the attachment of other viruses, identifying the specific cell types involved, and analyzing the effect of the cell cycle on virus binding.

AB - Epstein-Barr virus (EBV) was purified and biotinylated without significant loss of its cell-transforming activity. The use of biotinylated virus in conjunction with antibodies specific for selected cell surface molecules and flow cytometric analysis allowed for the positive identification of the virus-binding lymphocytes among a heterogeneous mononuclear cell population. Biotinylated EBV efficiently bound to all B lymphocytes, including those bearing surface μ, δ, γ and α immunoglobulin heavy chains or the surface CD5 (Leu-1) marker, but not to T lymphocytes, natural killer cells. or monocytes. By using biotinylated EBV and specific monoclonal antibodies in competitive inhibition experiments, it was also found that the virus attaches to an epitope on the CR2 molecule (the receptor for C3d and EBV), which is close to or identical with the one recognized by OKB7 monoclonal antibody, and that cell surface structures other than CR2 cannot mediate attachment of EBV. Moreover, studies on the binding of the virus to induced B lymphocytes at different stages of the cell cycle revealed that the virus failed to transform proliferating B lymphocytes (cells in S through G2 phase), and this was associated with the disappearance of the surface CR2 molecule and the inability of the virus to attach to these cells. The approach described here should be useful in studying the attachment of other viruses, identifying the specific cell types involved, and analyzing the effect of the cell cycle on virus binding.

UR - http://www.scopus.com/inward/record.url?scp=0023923170&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023923170&partnerID=8YFLogxK

M3 - Article

C2 - 2836625

AN - SCOPUS:0023923170

VL - 62

SP - 2453

EP - 2463

JO - Journal of Virology

JF - Journal of Virology

SN - 0022-538X

IS - 7

ER -